The FDA has approved this drug, but across New England there’s worry that the drug will only add fuel to the fire of the region’s opiate addiction problem. Lawmakers, governors, health care leaders, are all weighing in with different ideas about how to avoid abuse and yet still help those patients in pain.
State lawmakers are wading into the debate over the controversial new painkiller Zohydro.
A Senate committee will take up legislation Tuesday that would impose an 18-month moratorium on the new drug, an especially potent formulation of hydrocodone.
Zohydro hit the market in March and is aimed at patients who need long-term, around-the-clock pain relief. It differs from other hydrocodone-based medications, such as Vicodin, because it isn’t combined with acetaminophen or ibuprofen.
New numbers show the Granite State is near the top when it comes to abusing painkillers. Also, New Hampshire is one of only two states that does not monitor the purchases of these medications. We’ll explore that latest on this issue, and what some are in New Hampshire are doing to reverse these sobering numbers.